Elliptic Laboratories ASA
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Elliptic Laboratories ASA generated cash of -$45,509,000, which is less than the previous year. Cash used in financing activities reached the amount of $2,206,000 last year. Net change in cash is therefore -$62,637,000.
Cash Flow
| 2017 | -38.86M | -1.37M | 46.93M |
|---|---|---|---|
| 2018 | -35.15M | -8.73M | 23.23M |
| 2019 | -8.04M | -11.09M | 38.38M |
| 2020 | -6.67M | -15.10M | 87.19M |
| 2021 | -10.82M | -17.61M | 146.8M |
| 2022 | -12.75M | -23.32M | -4.26M |
| 2023 | -45.50M | -20.97M | 2.20M |
ELABS.OL Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 178.21M | 218.15M | 99.72M | 34.36M | 16.62M | 37.33M | 30.78M |
Operating activities | |||||||
Net income | -38.00M | -39.30M | -13.09M | -15.55M | -16.96M | -33.23M | -43.48M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 4.63M | 11.31M | 8.31M | 5.43M | 4.39M | 2.11M | 1.93M |
Stock-based compensation expense | 9.84M | 12.46M | 10.34M | 4.03M | 2.87M | 0 | 2.17M |
| Deferred income tax benefit | 9.84M | 12.46M | 10.34M | 4.03M | 2.87M | 0 | 2.17M |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | -20.11M | -11.46M | -28.59M | -450.80K | -741.64K | 0 | -1.82M |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 2.18M | -1.36M | 2.04M | 154.08K | -1.69M | 0 | -1.27M |
Cash generated by operating activities | -45.50M | -12.75M | -10.82M | -6.67M | -8.04M | -35.15M | -38.86M |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -514K | -23.32M | -17.61M | -15.10M | -11.09M | -8.73M | -1.37M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -20.97M | -23.32M | -17.61M | -15.10M | -11.09M | -8.73M | -1.37M |
Financing activities | |||||||
Common Stock Issued | 9.49M | 2.97M | 162.21M | 125.04M | 43.01M | 0 | 50M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -4M | -3.20M | -4M | -25M | 0 | 0 | -2M |
Cash used in financing activities | 2.20M | -4.26M | 146.8M | 87.19M | 38.38M | 23.23M | 46.93M |
Net Change In Cash | -62.63M | -39.93M | 118.42M | 65.36M | 19.24M | -20.71M | 6.55M |
Cash at end of period | 115.58M | 178.21M | 218.15M | 99.72M | 35.87M | 16.62M | 37.33M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |